Document is current
Any future updates will be listed below
-
Authors
Toledo, Míriam https://orcid.org/0000-0002-1332-7454
Martínez-Martínez, Sara https://orcid.org/0000-0002-7258-9083
Van Hul, Matthias
Laudo, Berta https://orcid.org/0009-0002-0918-9113
Eyre, Elena https://orcid.org/0000-0002-5858-9036
Pelicaen, Rudy
Puel, Anthony
Altirriba, Jordi https://orcid.org/0000-0002-8922-2333
Gómez-Valadés, Alicia G.
Inderhees, Julica
Moreno-Indias, Isabel
Pozo, Macarena https://orcid.org/0000-0003-0723-2499
Chivite, Iñigo https://orcid.org/0000-0002-2201-9998
Milà-Guasch, Maria
Haddad-Tóvolli, Roberta https://orcid.org/0000-0002-1739-3205
Obri, Arnaud
Fos-Domènech, Júlia
Tahiri, Iasim
Llana, Sergio R. https://orcid.org/0000-0003-3703-8355
Ramírez, Sara
Monelli, Erika https://orcid.org/0000-0002-0541-0602
Schwaninger, Markus https://orcid.org/0000-0002-4510-9718
Cani, Patrice D. https://orcid.org/0000-0003-2040-2448
Nogueiras, Rubén https://orcid.org/0000-0002-9976-9930
Claret, Marc https://orcid.org/0000-0001-7766-9296
-
Funding
Funding for this research was provided by:
"la Caixa" Foundation (LCF/PR/HR19/52160016)
- License Information
-
More Information
Article History
Received: 30 April 2024
Accepted: 17 March 2025
First Online: 22 April 2025
Competing interests
: P.D.C. is the inventor in patent applications dealing with the use of specific bacteria and components in the treatment of different diseases. P.D.C. was co-founder of the Akkermansia Company and Enterosys. Rubén Nogueiras serves in the Advisory Board of Albor Biotech. The other authors declare no competing interests.
